TXD

Home > Chemotherapeutics > TXD

From FEAR To FAITH

TXD

Docetaxel

Class

Antimicrotubule Agents (Taxanes)

MOA

Docetaxel is believed to have a twofold mechanism of antineoplastic activity:
(1) inhibition of microtubular de-polymerization.
(2) attenuation of the effects of bcl-2 and bcl-xL gene expression.

Indications

Breast cancer
Non-small cell lung cancer
Prostate cancer

Gastric adenocarcinoma
Head and neck cancer

Pack Size
1’s
Storage
Below 25° C
Available Strength
20mg /6ml Injection
80mg /6ml Injection
120mg /6ml Injection